Effect of folic acid supplementation on plasma asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase.

被引：0

作者：

Title, LM ^{[1
]}

Cummings, PM ^{[1
]}

Giddens, K ^{[1
]}

Nassar, BA ^{[1
]}

机构：

[1] Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada

来源：

CIRCULATION | 2000年 / 102卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

294

引用

页码：62 / 62

页数：1

共 50 条

[21] Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery
Maas, Renke
Dentz, Lena
Schwedhelm, Edzard
Thoms, Wolfgang
Kuss, Oliver
Hiltmeyer, Natascha
Haddad, Munif
Kloess, Thomas
Standl, Thomas
Boeger, Rainer H.
CRITICAL CARE MEDICINE, 2007, 35 (08) : 1876 - 1881
[22] Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice
Gunduz, Ozgur
Karadag, Cetin Hakan
Ulugol, Ahmet
JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (09) : 1027 - 1032
[23] Implication of Endogenous Nitric Oxide Synthase Inhibitor Asymmetric Dimethylarginine in the Contractile Dysfunction of Skeletal Muscles in Diabetic Rats
Xiong, Yan
Lei, Yan-Ping
Li, Xiao-Mei
Huang, Cheng
He, Yu-Lian
He, Zhi-Min
DIABETES, 2016, 65 : A194 - A194
[24] Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, increases the risk of cardiovascular disease and mortality in humans
Boger, RH
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2006, 14 (04): : A11 - A11
[25] Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice
Ozgur Gunduz
Cetin Hakan Karadag
Ahmet Ulugol
Journal of Neural Transmission, 2010, 117 : 1027 - 1032
[26] Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor
Jin, JS
DAlecy, LG
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (03) : 439 - 446
[27] Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects
Cable, David George
Celotto, Andrea Carla
Barbosa Evora, Paulo Roberto
Schaff, Hartzell Vernon
MEDICAL SCIENCE MONITOR, 2009, 15 (09): : BR248 - BR253
[28] Agmatine (decarboxylated arginine) is an endogenous inhibitor of all isoforms of mammalian nitric oxide synthase.
Galea, E
Regunathan, S
Eliopoulos, V
Feinstein, DL
Reis, DJ
JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S92 - S92
[29] Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine
Thum, T
Tsikas, D
Stein, S
Schultheiss, M
Eigenthaler, M
Anker, SD
Poole-Wilson, PA
Ertl, G
Bauersachs, J
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (09) : 1693 - 1701
[30] Cardiovascular effects of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) and evidence for ADMA metabolism in humans in vivo
Achan, V
Broadhead, M
Malaki, M
Leiper, J
MacAllister, R
Vallance, P
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 303A - 303A

← 1 2 3 4 5 →